Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.32 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.31 |
| ▸ | GABRP | O00591 | 1/20 | 0.31 |
| ▸ | GABRD | O14764 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.31 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.31 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10153690 | 0.78 | ALKBH5 (0.41) | ALKBH5FTOGPR3 | |
| SCHEMBL30526402 | 0.73 | NLRP3 (0.40) | NLRP3PTPN1MCL1DDB1CRBN | |
| SCHEMBL10153466 | 0.73 | — | — | |
| SCHEMBL10313391 | 0.73 | NR1H2 (0.34) | — | |
| SCHEMBL10153695 | 0.68 | MAOA (0.37) | — | |
| SCHEMBL12165652 | 0.67 | NLRP3 (0.49) | NLRP3PTPN1MCL1ALKBH5FTO | |
| SCHEMBL10313371 | 0.65 | GPR3 (0.34) | ALKBH5FTOGPR3 | |
| SCHEMBL21889374 | 0.64 | NLRP3 (0.46) | NLRP3PTPN1MCL1ALKBH5FTO | |
| SCHEMBL12165640 | 0.64 | NLRP3 (0.46) | NLRP3PTPN1MCL1 | |
| SCHEMBL10313384 | 0.64 | SMN1; SMN2 (0.36) | ALKBH5FTOGPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8421066-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2013-04-16 | — | — | US | disclosed |
| US-8421066-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2013-04-16 | — | — | US | disclosed |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-8174002-B2 | Organic electroluminescence device | FUJIFILM CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| US-8174002-B2 | Organic electroluminescence device | FUJIFILM CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2010-03-04 | — | — | US | disclosed |
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, LEF1 | NLRP3 1800/4885PTPN1 3430/4885MCL1 397/4885 |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, LEF1 | NLRP3 1800/4885PTPN1 3430/4885MCL1 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.